Literature DB >> 19794089

G-CSF receptor (CSF3R) mutations in X-linked neutropenia evolving to acute myeloid leukemia or myelodysplasia.

Karolien Beel1, Peter Vandenberghe.   

Abstract

X-linked neutropenia (XLN) is a rare form of Congenital Neutropenia (CN) caused by inherited gain-of-function mutations of WAS. Here we report 2 cases of the original L270P X-linked neutropenia kindred that evolved to MDS or AML, with acquisition of G-CSFR (CSF3R) mutations and monosomy 7. Thus, leukemic transformation with acquisition of CSF3R mutations and monosomy 7 is not restricted to classical congenital neutropenia with autosomal inheritance, but can also occur in other genotypes of inherited neutropenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19794089      PMCID: PMC2754963          DOI: 10.3324/haematol.2009.009001

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  28 in total

1.  Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

2.  Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia.

Authors:  K Devriendt; A S Kim; G Mathijs; S G Frints; M Schwartz; J J Van Den Oord; G E Verhoef; M A Boogaerts; J P Fryns; D You; M K Rosen; P Vandenberghe
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

Review 3.  Childhood monosomy 7: epidemiology, biology, and mechanistic implications.

Authors:  S Luna-Fineman; K M Shannon; B J Lange
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

4.  Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy.

Authors:  M H Freedman; M A Bonilla; C Fier; A A Bolyard; D Scarlata; L A Boxer; S Brown; B Cham; G Kannourakis; S E Kinsey; P G Mori; T Cottle; K Welte; D C Dale
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

5.  Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.

Authors:  F Dong; D C Dale; M A Bonilla; M Freedman; A Fasth; H J Neijens; J Palmblad; G L Briars; G Carlsson; A J Veerman; K Welte; B Löwenberg; I P Touw
Journal:  Leukemia       Date:  1997-01       Impact factor: 11.528

6.  Proposals for the classification of the myelodysplastic syndromes.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

7.  Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.

Authors:  F Dong; R K Brynes; N Tidow; K Welte; B Löwenberg; I P Touw
Journal:  N Engl J Med       Date:  1995-08-24       Impact factor: 91.245

8.  Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia.

Authors:  Andrew A G Aprikyan; Tatyana Kutyavin; Steven Stein; Pavel Aprikian; Elin Rodger; W Conrad Liles; Laurence A Boxer; David C Dale
Journal:  Exp Hematol       Date:  2003-05       Impact factor: 3.084

9.  Transient expression of trisomy 21 and monosomy 7 following cyclosporin A in a patient with aplastic anemia.

Authors:  N J Barrios; D V Kirkpatrick; M L Levin; M Varela
Journal:  Leuk Res       Date:  1991       Impact factor: 3.156

10.  Cytogenetic analysis and clinical significance of chromosome 7 aberrations in acute leukaemia.

Authors:  Izabela Brozek; Małgorzata Babińska; Iwona Kardaś; Agnieszka Woźniak; Anna Balcerska; Andrzej Hellmann; Janusz Limon
Journal:  J Appl Genet       Date:  2003       Impact factor: 3.240

View more
  11 in total

1.  Case 2: Where have all the white cells gone?

Authors:  Ryan Nelson; Michele Cho; Eyal Ben-Isaac
Journal:  Paediatr Child Health       Date:  2010-11       Impact factor: 2.253

2.  Molecular basis of congenital neutropenia.

Authors:  Christoph Klein
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

3.  A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.

Authors:  Yaling Qiu; Yangyang Zhang; Nan Hu; Fan Dong
Journal:  J Biol Chem       Date:  2017-01-10       Impact factor: 5.157

4.  Somatic mutations and clonal hematopoiesis in congenital neutropenia.

Authors:  Jun Xia; Christopher A Miller; Jack Baty; Amrita Ramesh; Matthew R M Jotte; Robert S Fulton; Tiphanie P Vogel; Megan A Cooper; Kelly J Walkovich; Vahagn Makaryan; Audrey A Bolyard; Mary C Dinauer; David B Wilson; Adrianna Vlachos; Kasiani C Myers; Robert J Rothbaum; Alison A Bertuch; David C Dale; Akiko Shimamura; Laurence A Boxer; Daniel C Link
Journal:  Blood       Date:  2017-11-01       Impact factor: 22.113

Review 5.  Dysplasia has A differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors.

Authors:  David P Steensma
Journal:  Curr Hematol Malig Rep       Date:  2012-12       Impact factor: 3.952

Review 6.  Congenital neutropenia: diagnosis, molecular bases and patient management.

Authors:  Jean Donadieu; Odile Fenneteau; Blandine Beaupain; Nizar Mahlaoui; Christine Bellanné Chantelot
Journal:  Orphanet J Rare Dis       Date:  2011-05-19       Impact factor: 4.123

Review 7.  Neutropenia in primary immunodeficiency.

Authors:  Robert Sokolic
Journal:  Curr Opin Hematol       Date:  2013-01       Impact factor: 3.284

8.  Inference of surface membrane factors of HIV-1 infection through functional interaction networks.

Authors:  Samira Jaeger; Gokhan Ertaylan; David van Dijk; Ulf Leser; Peter Sloot
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

9.  Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS.

Authors:  Peter Vandenberghe; Karolien Beel
Journal:  Pediatr Rep       Date:  2011-06-22

Review 10.  Hematopoietic Stem Cell Therapy for Wiskott-Aldrich Syndrome: Improved Outcome and Quality of Life.

Authors:  Kanwaldeep K Mallhi; Aleksandra Petrovic; Hans D Ochs
Journal:  J Blood Med       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.